Works by Usuki, Kensuke


Results: 121
    1

    Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 6, p. 1689, doi. 10.1111/bjh.20097
    By:
    • Maeda, Tomoya;
    • Matsuda, Akira;
    • Kanda, Junya;
    • Kawabata, Hiroshi;
    • Ishikawa, Takayuki;
    • Tohyama, Kaoru;
    • Kitanaka, Akira;
    • Araseki, Kayano;
    • Shimbo, Kei;
    • Hata, Tomoko;
    • Suzuki, Takahiro;
    • Kayano, Hidekazu;
    • Usuki, Kensuke;
    • Shindo‐Ueda, Maki;
    • Arima, Nobuyoshi;
    • Nohgawa, Masaharu;
    • Ohta, Akiko;
    • Chiba, Shigeru;
    • Miyazaki, Yasushi;
    • Nakao, Shinji
    Publication type:
    Article
    2
    3

    Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351.

    Published in:
    International Journal of Hematology, 2025, v. 122, n. 1, p. 57, doi. 10.1007/s12185-025-03956-8
    By:
    • Makishima, Hideki;
    • Mikasa, Taisuke;
    • Isogaya, Kento;
    • Miyamoto, Toshihiro;
    • Yamauchi, Takuji;
    • Yokota, Akira;
    • Onozawa, Masahiro;
    • Ando, Kiyoshi;
    • Ogawa, Yoshiaki;
    • Usuki, Kensuke;
    • Yamauchi, Takahiro;
    • Ota, Shuichi;
    • Takada, Satoru;
    • Morita, Yasuyoshi;
    • Ishikawa, Takayuki;
    • Takenaka, Katsuto;
    • Kuroda, Junya;
    • Sekiguchi, Naohiro;
    • Kawakita, Toshiro;
    • Miyazaki, Yasushi
    Publication type:
    Article
    4

    A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02.

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 3, p. 378, doi. 10.1007/s12185-024-03895-w
    By:
    • Arai, Hironori;
    • Hosono, Naoko;
    • Chi, SungGi;
    • Fukushima, Kentaro;
    • Ikeda, Daisuke;
    • Iyama, Satoshi;
    • Gotoh, Akihiko;
    • Ikezoe, Takayuki;
    • Yoshida, Chikashi;
    • Yoshimoto, Goichi;
    • Kanda, Junya;
    • Takahashi, Naoto;
    • Sakaida, Emiko;
    • Usuki, Kensuke;
    • Yamauchi, Takahiro;
    • Minami, Yosuke
    Publication type:
    Article
    5

    A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 1, p. 68, doi. 10.1007/s12185-024-03872-3
    By:
    • Kosugi, Hiroshi;
    • Fujisaki, Tomoaki;
    • Iwasaki, Hiromi;
    • Shinagawa, Atsushi;
    • Iida, Hiroatsu;
    • Jo, Tatsuro;
    • Kubonishi, Shiro;
    • Morita, Yasuyoshi;
    • Nakashima, Yasuhiro;
    • Onodera, Koichi;
    • Suzuki, Kenshi;
    • Suzuki, Takahiro;
    • Tamai, Yotaro;
    • Usuki, Kensuke;
    • Yokota, Akira;
    • Yonaga, Hideyuki;
    • Hayakawa, Jin;
    • Midorikawa, Shuichi;
    • Nishio, Mitsufumi;
    • Suda, Makoto
    Publication type:
    Article
    6

    Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in Japan.

    Published in:
    International Journal of Hematology, 2024, v. 120, n. 6, p. 684, doi. 10.1007/s12185-024-03862-5
    By:
    • Sugimoto, Yuka;
    • Nagaharu, Keiki;
    • Ohya, Eiko;
    • Ohishi, Kohshi;
    • Tawara, Isao;
    • Ito, Tomoki;
    • Gotoh, Akihiko;
    • Nakamae, Mika;
    • Kimura, Fumihiko;
    • Koike, Michiaki;
    • Kirito, Keita;
    • Wada, Hideho;
    • Usuki, Kensuke;
    • Tanaka, Takayuki;
    • Mori, Takehiko;
    • Wakita, Satoshi;
    • Saito, Toshiki I.;
    • Saito, Akiko M.;
    • Shimoda, Kazuya;
    • Kurokawa, Toshiro
    Publication type:
    Article
    7

    Survival impact of response within the first year in a multicenter prospective observational study of chronic GVHD in a Japanese cohort.

    Published in:
    International Journal of Hematology, 2024, v. 120, n. 3, p. 347, doi. 10.1007/s12185-024-03813-0
    By:
    • Ohwada, Chikako;
    • Sakaida, Emiko;
    • Takeda, Yusuke;
    • Doki, Noriko;
    • Igarashi, Aiko;
    • Onizuka, Makoto;
    • Toyosaki, Masako;
    • Tanaka, Masatsugu;
    • Tachibana, Takayoshi;
    • Kataoka, Keisuke;
    • Kato, Jun;
    • Fujisawa, Shin;
    • Kato, Seiko;
    • Nakasone, Hideki;
    • Naganuma, Ken;
    • Saitoh, Takayuki;
    • Shono, Katsuhiro;
    • Hagihara, Maki;
    • Saito, Takeshi;
    • Usuki, Kensuke
    Publication type:
    Article
    8

    Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.

    Published in:
    International Journal of Hematology, 2024, v. 119, n. 6, p. 722, doi. 10.1007/s12185-024-03740-0
    By:
    • Usuki, Kensuke;
    • Kameda, Takuro;
    • Kawano, Noriaki;
    • Ito, Tomoki;
    • Hashimoto, Yoshinori;
    • Shide, Kotaro;
    • Kawano, Hiroshi;
    • Sekine, Masaaki;
    • Toyama, Takanori;
    • Iizuka, Hiromitsu;
    • Sato, Seiichi;
    • Takeuchi, Masanori;
    • Ishizaki, Junzo;
    • Maeda, Kouichi;
    • Nakai, Michikazu;
    • Yamashita, Kiyoshi;
    • Kubuki, Yoko;
    • Shimoda, Kazuya
    Publication type:
    Article
    9

    A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia.

    Published in:
    International Journal of Hematology, 2024, v. 119, n. 6, p. 647, doi. 10.1007/s12185-024-03733-z
    By:
    • Usuki, Kensuke;
    • Miyamoto, Toshihiro;
    • Yamauchi, Takuji;
    • Ando, Kiyoshi;
    • Ogawa, Yoshiaki;
    • Onozawa, Masahiro;
    • Yamauchi, Takahiro;
    • Kiyoi, Hitoshi;
    • Yokota, Akira;
    • Ikezoe, Takayuki;
    • Katsuoka, Yuna;
    • Takada, Satoru;
    • Aotsuka, Nobuyuki;
    • Morita, Yasuyoshi;
    • Ishikawa, Takayuki;
    • Asada, Noboru;
    • Ota, Shuichi;
    • Dohi, Atsushi;
    • Morimoto, Kensaku;
    • Imai, Shunji
    Publication type:
    Article
    10
    11
    12

    Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

    Published in:
    International Journal of Hematology, 2024, v. 119, n. 2, p. 130, doi. 10.1007/s12185-023-03686-9
    By:
    • Usuki, Kensuke;
    • Ohtake, Shigeki;
    • Honda, Sumihisa;
    • Matsuda, Mitsuhiro;
    • Wakita, Atsushi;
    • Nawa, Yuichiro;
    • Takase, Ken;
    • Maeda, Akio;
    • Sezaki, Nobuo;
    • Yokoyama, Hisayuki;
    • Takada, Satoru;
    • Hirano, Daiki;
    • Tomikawa, Tatsuki;
    • Sumi, Masahiko;
    • Yano, Shingo;
    • Handa, Hiroshi;
    • Ota, Shuichi;
    • Fujita, Hiroyuki;
    • Fujimaki, Katsumichi;
    • Mugitani, Atsuko
    Publication type:
    Article
    13

    Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

    Published in:
    International Journal of Hematology, 2024, v. 119, n. 1, p. 24, doi. 10.1007/s12185-023-03677-w
    By:
    • Usuki, Kensuke;
    • Ohtake, Shigeki;
    • Honda, Sumihisa;
    • Matsuda, Mitsuhiro;
    • Wakita, Atsushi;
    • Nawa, Yuichiro;
    • Takase, Ken;
    • Maeda, Akio;
    • Sezaki, Nobuo;
    • Yokoyama, Hisayuki;
    • Takada, Satoru;
    • Hirano, Daiki;
    • Tomikawa, Tatsuki;
    • Sumi, Masahiko;
    • Yano, Shingo;
    • Handa, Hiroshi;
    • Ota, Shuichi;
    • Fujita, Hiroyuki;
    • Fujimaki, Katsumichi;
    • Mugitani, Atsuko
    Publication type:
    Article
    14
    15

    Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

    Published in:
    International Journal of Hematology, 2023, v. 118, n. 1, p. 47, doi. 10.1007/s12185-023-03592-0
    By:
    • Edahiro, Yoko;
    • Ochiai, Tomonori;
    • Hashimoto, Yoshinori;
    • Morishita, Soji;
    • Shirane, Shuichi;
    • Inano, Tadaaki;
    • Furuya, Chiho;
    • Koike, Michiaki;
    • Noguchi, Masaaki;
    • Usuki, Kensuke;
    • Shiratsuchi, Motoaki;
    • Nakajima, Kei;
    • Ohtsuka, Eiichi;
    • Tanaka, Hiroaki;
    • Kawata, Eri;
    • Nakamae, Mika;
    • Ueda, Yasunori;
    • Aota, Yasuo;
    • Sugita, Yasumasa;
    • Ohara, Shin
    Publication type:
    Article
    16
    17
    18
    19
    20

    Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.

    Published in:
    International Journal of Hematology, 2022, v. 116, n. 2, p. 215, doi. 10.1007/s12185-022-03341-9
    By:
    • Edahiro, Yoko;
    • Ohishi, Kohshi;
    • Gotoh, Akihiko;
    • Takenaka, Katsuto;
    • Shibayama, Hirohiko;
    • Shimizu, Takayuki;
    • Usuki, Kensuke;
    • Shimoda, Kazuya;
    • Ito, Masafumi;
    • VanWart, Scott A.;
    • Zagrijtschuk, Oleh;
    • Qin, Albert;
    • Kawase, Hiroaki;
    • Miyachi, Narihisa;
    • Sato, Toshiaki;
    • Komatsu, Norio;
    • Kirito, Keita
    Publication type:
    Article
    21

    NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia.

    Published in:
    International Journal of Hematology, 2022, v. 116, n. 2, p. 199, doi. 10.1007/s12185-022-03328-6
    By:
    • Marumo, Atsushi;
    • Wakita, Satoshi;
    • Morita, Kaoru;
    • Oh, Iekuni;
    • Kako, Shinichi;
    • Toya, Takashi;
    • Najima, Yuho;
    • Doki, Noriko;
    • Kanda, Junya;
    • Kuroda, Junya;
    • Mori, Shinichiro;
    • Satake, Atsushi;
    • Usuki, Kensuke;
    • Uoshima, Nobuhiko;
    • Kobayashi, Yutaka;
    • Kawata, Eri;
    • Nagao, Yuhei;
    • Shono, Katsuhiro;
    • Shibusawa, Motoharu;
    • Tadokoro, Jiro
    Publication type:
    Article
    22

    Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.

    Published in:
    International Journal of Hematology, 2022, v. 116, n. 2, p. 228, doi. 10.1007/s12185-022-03347-3
    By:
    • Miyazaki, Yasushi;
    • Kiguchi, Toru;
    • Sato, Shinya;
    • Usuki, Kensuke;
    • Ishiyama, Ken;
    • Ito, Yoshikazu;
    • Suzuki, Takahiro;
    • Taguchi, Jun;
    • Chiba, Shigeru;
    • Dobashi, Nobuaki;
    • Tomita, Akihiro;
    • Harada, Hironori;
    • Handa, Hiroshi;
    • Horiike, Shigeo;
    • Maeda, Tomoya;
    • Matsuda, Mitsuhiro;
    • Ichikawa, Motoshi;
    • Hata, Tomoko;
    • Honda, Sumihisa;
    • Iyama, Satoshi
    Publication type:
    Article
    23
    24

    Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study.

    Published in:
    International Journal of Hematology, 2022, v. 115, n. 2, p. 208, doi. 10.1007/s12185-021-03253-0
    By:
    • Hashimoto, Yoshinori;
    • Ito, Tomoki;
    • Gotoh, Akihiko;
    • Nakamae, Mika;
    • Kimura, Fumihiko;
    • Koike, Michiaki;
    • Kirito, Keita;
    • Wada, Hideho;
    • Usuki, Kensuke;
    • Tanaka, Takayuki;
    • Mori, Takehiko;
    • Wakita, Satoshi;
    • Saito, Toshiki I.;
    • Kada, Akiko;
    • Saito, Akiko M.;
    • Shimoda, Kazuya;
    • Sugimoto, Yuka;
    • Kurokawa, Toshiro;
    • Tomita, Akihiro;
    • Edahiro, Yoko
    Publication type:
    Article
    25
    26

    Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.

    Published in:
    International Journal of Hematology, 2020, v. 112, n. 4, p. 466, doi. 10.1007/s12185-020-02934-6
    By:
    • Ishiyama, Ken;
    • Nakao, Shinji;
    • Usuki, Kensuke;
    • Yonemura, Yuji;
    • Ikezoe, Takayuki;
    • Uchiyama, Michihiro;
    • Mori, Yasuo;
    • Fukuda, Tetsuya;
    • Okada, Masaya;
    • Fujiwara, Shin-ichiro;
    • Noji, Hideyoshi;
    • Rottinghaus, Scott;
    • Aguzzi, Rasha;
    • Yokosawa, Jun;
    • Nishimura, Jun-Ichi;
    • Kanakura, Yuzuru;
    • Okamoto, Shinichiro
    Publication type:
    Article
    27

    The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse.

    Published in:
    International Journal of Hematology, 2020, v. 112, n. 2, p. 200, doi. 10.1007/s12185-020-02894-x
    By:
    • Kurosawa, Saiko;
    • Yamaguchi, Hiroki;
    • Yamaguchi, Takuhiro;
    • Fukunaga, Keiko;
    • Yui, Shunsuke;
    • Kanamori, Heiwa;
    • Usuki, Kensuke;
    • Uoshima, Nobuhiko;
    • Yanada, Masamitsu;
    • Takeuchi, Jin;
    • Mizuno, Ishikazu;
    • Kanda, Junya;
    • Okamura, Hiroshi;
    • Yano, Shingo;
    • Tashiro, Haruko;
    • Shindo, Takero;
    • Chiba, Shigeru;
    • Tomiyama, Junji;
    • Inokuchi, Koiti;
    • Fukuda, Takahiro
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.

    Published in:
    2018
    By:
    • Takahashi, Naoto;
    • Tauchi, Tetsuzo;
    • Kitamura, Kunio;
    • Miyamura, Koichi;
    • Saburi, Yoshio;
    • Hatta, Yoshihiro;
    • Miyata, Yasuhiko;
    • Kobayashi, Shinichi;
    • Usuki, Kensuke;
    • Matsumura, Itaru;
    • Minami, Yosuke;
    • Usui, Noriko;
    • Fukuda, Tetsuya;
    • Takada, Satoru;
    • Ishikawa, Maho;
    • Fujimaki, Katsumichi;
    • Gomyo, Hiroshi;
    • Sasaki, Osamu;
    • Ohishi, Kohshi;
    • Miyake, Takaaki
    Publication type:
    journal article
    35

    Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry.

    Published in:
    2017
    By:
    • Kawabata, Hiroshi;
    • Tohyama, Kaoru;
    • Matsuda, Akira;
    • Araseki, Kayano;
    • Hata, Tomoko;
    • Suzuki, Takahiro;
    • Kayano, Hidekazu;
    • Shimbo, Kei;
    • Zaike, Yuji;
    • Usuki, Kensuke;
    • Chiba, Shigeru;
    • Ishikawa, Takayuki;
    • Arima, Nobuyoshi;
    • Nogawa, Masaharu;
    • Ohta, Akiko;
    • Miyazaki, Yasushi;
    • Mitani, Kinuko;
    • Ozawa, Keiya;
    • Arai, Shunya;
    • Kurokawa, Mineo
    Publication type:
    journal article
    36
    37

    Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.

    Published in:
    2017
    By:
    • Ogura, Michinori;
    • Ishizawa, Kenichi;
    • Maruyama, Dai;
    • Uike, Naokuni;
    • Ando, Kiyoshi;
    • Izutsu, Koji;
    • Terui, Yasuhito;
    • Imaizumi, Yoshitaka;
    • Tsukasaki, Kunihiro;
    • Suzuki, Kenshi;
    • Izumi, Tohru;
    • Usuki, Kensuke;
    • Kinoshita, Tomohiro;
    • Taniwaki, Masafumi;
    • Uoshima, Nobuhiko;
    • Suzumiya, Junji;
    • Kurosawa, Mitsutoshi;
    • Nagai, Hirokazu;
    • Uchida, Toshiki;
    • Fukuhara, Noriko
    Publication type:
    journal article
    38

    Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan.

    Published in:
    2017
    By:
    • Takenaka, Katsuto;
    • Shimoda, Kazuya;
    • Uchida, Naoyuki;
    • Shimomura, Taizo;
    • Nagafuji, Koji;
    • Kondo, Tadakazu;
    • Shibayama, Hirohiko;
    • Mori, Takehiko;
    • Usuki, Kensuke;
    • Azuma, Taichi;
    • Tsutsumi, Yutaka;
    • Tanaka, Junji;
    • Dairaku, Hitomi;
    • Matsuo, Keitaro;
    • Ozawa, Keiya;
    • Kurokawa, Mineo;
    • Arai, Shunya;
    • Akashi, Koichi
    Publication type:
    journal article
    39

    Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.

    Published in:
    2016
    By:
    • Ninomiya, Haruhiko;
    • Obara, Naoshi;
    • Chiba, Shigeru;
    • Usuki, Kensuke;
    • Nishiwaki, Kaichi;
    • Matsumura, Itaru;
    • Shichishima, Tsutomu;
    • Okamoto, Shinichiro;
    • Nishimura, Jun-ichi;
    • Ohyashiki, Kazuma;
    • Nakao, Shinji;
    • Ando, Kiyoshi;
    • Kanda, Yoshinobu;
    • Kawaguchi, Tatsuya;
    • Nakakuma, Hideki;
    • Harada, Daisuke;
    • Akiyama, Hirozumi;
    • Kinoshita, Taroh;
    • Ozawa, Keiya;
    • Omine, Mitsuhiro
    Publication type:
    journal article
    40
    41

    Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up.

    Published in:
    International Journal of Hematology, 2014, v. 99, n. 2, p. 141, doi. 10.1007/s12185-013-1470-1
    By:
    • Fujisawa, Shin;
    • Nakamae, Hirohisa;
    • Ogura, Michinori;
    • Ishizawa, Ken-ichi;
    • Taniwaki, Masafumi;
    • Utsunomiya, Atae;
    • Matsue, Kosei;
    • Takamatsu, Yasushi;
    • Usuki, Kensuke;
    • Tanimoto, Mitsune;
    • Ishida, Yoji;
    • Akiyama, Hideki;
    • Onishi, Shintaro
    Publication type:
    Article
    42

    An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP).

    Published in:
    International Journal of Hematology, 2012, v. 95, n. 6, p. 652, doi. 10.1007/s12185-012-1065-2
    By:
    • Shirasugi, Yukari;
    • Ando, Kiyoshi;
    • Miyazaki, Koji;
    • Tomiyama, Yoshiaki;
    • Iwato, Koji;
    • Okamoto, Shinichiro;
    • Kurokawa, Mineo;
    • Kirito, Keita;
    • Hashino, Satoshi;
    • Ninomiya, Haruhiko;
    • Mori, Shinichiro;
    • Yonemura, Yuji;
    • Usuki, Kensuke;
    • Wei, Helen;
    • Lizambri, Richard
    Publication type:
    Article
    43

    Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study.

    Published in:
    International Journal of Hematology, 2012, v. 95, n. 4, p. 409, doi. 10.1007/s12185-012-1026-9
    By:
    • Usuki, Kensuke;
    • Tojo, Arinobu;
    • Maeda, Yasuhiro;
    • Kobayashi, Yukio;
    • Matsuda, Akira;
    • Ohyashiki, Kazuma;
    • Nakaseko, Chiaki;
    • Kawaguchi, Tatsuya;
    • Tanaka, Hideo;
    • Miyamura, Koichi;
    • Miyazaki, Yasushi;
    • Okamoto, Shinichiro;
    • Oritani, Kenji;
    • Okada, Masaya;
    • Usui, Noriko;
    • Nagai, Tadashi;
    • Amagasaki, Taro;
    • Wanajo, Aira;
    • Naoe, Tomoki
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 01.

    Published in:
    Cancer Science, 2023, v. 114, n. 5, p. 2098, doi. 10.1111/cas.15746
    By:
    • Hosono, Naoko;
    • Chi, SungGi;
    • Yamauchi, Takahiro;
    • Fukushima, Kentaro;
    • Shibayama, Hirohiko;
    • Katagiri, Seiichiro;
    • Gotoh, Akihiko;
    • Eguchi, Motoki;
    • Morishita, Takanobu;
    • Ogasawara, Reiki;
    • Kondo, Takeshi;
    • Yanada, Masamitsu;
    • Yamamoto, Kazuhito;
    • Kobayashi, Tsutomu;
    • Kuroda, Junya;
    • Usuki, Kensuke;
    • Utsu, Yoshikazu;
    • Yoshimitsu, Makoto;
    • Ishitsuka, Kenji;
    • Ono, Takaaki
    Publication type:
    Article